These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29489879)

  • 21. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
    Wu YE; Peng WG; Cai YM; Zheng GZ; Zheng GL; Lin JH; Zhang SW; Li K
    Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
    Holmén N; Isaksson S; Simrén M; Sjövall H; Ohman L
    Neurogastroenterol Motil; 2007 Feb; 19(2):119-25. PubMed ID: 17244166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn's disease and discriminative value of FOXP3 mRNA expression.
    Ahuja V; Subodh S; Tuteja A; Mishra V; Garg SK; Gupta N; Makharia G; Acharya SK
    Gastroenterol Rep (Oxf); 2016 Feb; 4(1):59-67. PubMed ID: 25969456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating Crohn's disease from intestinal tuberculosis.
    Kedia S; Das P; Madhusudhan KS; Dattagupta S; Sharma R; Sahni P; Makharia G; Ahuja V
    World J Gastroenterol; 2019 Jan; 25(4):418-432. PubMed ID: 30700939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease.
    Zhang S; Qing Q; Wang Q; Xu J; Zhi F; Park PW; Zhang Y; Chen Y
    Inflamm Bowel Dis; 2013 Apr; 19(5):1025-33. PubMed ID: 23511033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.
    Wu YE; Du ZR; Cai YM; Peng WG; Zheng GZ; Zheng GL; Wu LB; Li K
    Mol Med Rep; 2015 Apr; 11(4):3134-42. PubMed ID: 25483347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
    Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
    Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of in vitro interferon-γ release assay in differential diagnosis between intestinal tuberculosis and Crohn's disease.
    Lei Y; Yi FM; Zhao J; Luckheeram RV; Huang S; Chen M; Huang MF; Li J; Zhou R; Yang GF; Xia B
    J Dig Dis; 2013 Feb; 14(2):68-75. PubMed ID: 23176201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus.
    Vorobjova T; Uibo O; Heilman K; Rägo T; Honkanen J; Vaarala O; Tillmann V; Ojakivi I; Uibo R
    Scand J Gastroenterol; 2009; 44(4):422-30. PubMed ID: 19096978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
    Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
    Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating Crohn's disease from intestinal tuberculosis at presentation in patients with tissue granulomas.
    Watermeyer G; Thomson S
    S Afr Med J; 2018 Apr; 108(5):399-402. PubMed ID: 29843853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy.
    Kim MJ; Lee WY; Choe YH
    Gut Liver; 2015 May; 9(3):370-80. PubMed ID: 25071071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased expressions of peripheral PD-1
    Li H; Li S; Hu S; Zou G; Hu Z; Wei H; Wang Y; Du X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jan; 33(1):81-84. PubMed ID: 28031121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of CD4+ CD25+ CD127(low) regulatory T cells and notch1 pathway in the pathogenesis of aplastic anemia].
    Yin XX; Liu CF; Li LZ; Chen WZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):308-11. PubMed ID: 18844067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.